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32 The Journal of Thoracic and Cardiobjective: Cardiopulmonary bypass has been shown to be associated with platelet
ysfunction, which has a potential for increasing the risk of perioperative bleeding.
ff-pump coronary artery bypass surgery is thought to avoid this deleterious effect
f pump use on platelets. However, the influence of off-pump coronary artery
ypass surgery on platelets has not been thoroughly studied.
ethods: Accordingly, we evaluated 60 patients undergoing coronary artery bypass
rafting prospectively using cardiopulmonary bypass and warm cardioplegic arrest
n  30) or an off-pump technique (n  30). Platelet function was evaluated before
nd 2 hours after coronary artery bypass grafting.
esults: Among patients undergoing on-pump coronary artery bypass surgery, all
tudies of platelet function were significantly abnormal after surgical intervention
ompared with results before surgical intervention. Similarly, among patients un-
ergoing off-pump coronary artery bypass surgery, evidence of platelet dysfunction
fter surgical intervention was noted, with a lower platelet count and a higher
roportion of P-selectin– and Annexin V–positive platelets. However, compared
ith the preprocedural value, the postprocedural decrease in platelet count (78,200
103/L vs 103,000  103/L) and platelet aggregation (0.8% vs 10.9%) and
ncrease in bleeding time (0 minutes vs 1.3 minutes), P-selectin–positive platelets
6.0% vs 9.1%), and Annexin V–positive platelets (1.7% vs 3.7%) were signifi-
antly lower in the off-pump coronary artery bypass surgery group compared with
hose in the on-pump coronary artery bypass surgery group, respectively.
onclusions: Early postoperative decrease in platelet count and increase in platelet
ctivation occurs to a much lesser extent and does not alter bleeding time or
denosine diphosphate–induced platelet aggregation in patients undergoing off-
ump coronary artery bypass surgery. This lack of significant effects on platelets
ight in part account for the potential decreased risk in bleeding and for the
reserved hemostasis seen in patients undergoing off-pump coronary artery bypass
urgery compared with those undergoing on-pump coronary artery bypass grafting
urgery.
ardiopulmonary bypass has been shown to be associated with platelet
dysfunction, which has a potential for increasing the risk of perioperative
bleeding and thrombotic complications.1-5 By avoiding cardiopulmonary
ypass, off-pump coronary artery bypass surgery (OPCAB) has been proposed to
void this deleterious effect of pump use on platelets.6-9 This hypothesis remain
ttractive but unproved, because there is less information on the influence of
PCAB on postoperative platelet function.10,11
vascular Surgery ● July 2007
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PAccordingly, the purpose of this investigation was to
valuate the preoperative and early postoperative platelet
unction among patients undergoing OPCAB, compared
ith that among patients undergoing on-pump coronary
rtery bypass surgery (ONCAB). We hypothesized that, in
ontrast to ONCAB, in which exposure to nonendothelial
urfaces of the pump results in a significant degree of
latelet activation, OPCAB would have a potentially minor
nfluence on platelet function.
aterials and Methods
e evaluated patients undergoing first-time coronary artery by-
ass grafting (CABG) at the Cardiothoracic Surgery Department,
airo University Hospitals, between June 24, 2003, and July 10,
004. We excluded patients with pre-existing coagulopathy or
ther disorders of hemostasis; those receiving aspirin, thienopyri-
ines, or glycoprotein IIb-IIIa inhibitors in the last 10 days before
he operation; those needing urgent or redo CABG; those needing
oncomitant valvular and left ventricular aneurysm operations; and
hose with hepatic or renal impairment. Findings on coronary
ngiography were used to guide the decision regarding the feasi-
ility and safety of OPCAB and ONCAB. In this prospective,
onrandomized cohort study, a total of 60 consecutive patients
ho met the study criteria underwent either OPCAB (n  30) or
NCAB (n  30). The study protocol was approved by the local
nstitutional review board, and informed consent was obtained
rom all patients.
urgical Protocol
ll patients underwent operations through a full median sternot-
my. The left internal thoracic artery was harvested in each patient
ith a conventional pleurotomy access. Additional conduits were
btained by harvesting the radial artery or segments of the great
aphenous vein. No patients received perioperative antifibrinolytic
rugs, and 325 mg/d aspirin was administered 6 hours after the
rocedure in both groups.
ONCAB technique. Cardiopulmonary bypass was instituted
y using ascending aortic cannulation and 2-stage venous cannu-
ation of the right atrium. A standard circuit was used: a Dideco
ubing set, a Stockert roller pump, and a hollow-fiber membrane
xygenator (Sorin Biomedica, Midhurst, United Kingdom). The
xtracorporeal circuit was primed with 1500 mL of Hartmann’s
olution, 0.5 g/kg mannitol, 10 mL of 10% calcium gluconate, and
0,000 IU of heparin. Nonpulsatile flow was used, and flow rates
hroughout bypass were 2.4 L · m2 · min1. Systemic temper-
ture was kept between 32°C and 36°C. Myocardial protection was
Abbreviations and Acronyms
ACT  activated clotting time
ADP  adenosine diphosphate
CABG  coronary artery bypass grafting
ONCAB on-pump coronary artery bypass surgery
OPCAB off-pump coronary artery bypass surgerychieved by using intermittent anterograde hyperkalemic warm p
The Journal of Thoraciclood cardioplegia. On completion of all distal anastomoses, the
ortic crossclamp was removed, and the proximal anastomoses
ere performed with partial clamping. During cardiopulmonary
ypass, when additional volume was required, this consisted of
artmann’s solution (provided the hematocrit level was greater
han 22%) or red blood cell concentrates (if the hematocrit level
ecreased to less than 22%).
OPCAB technique. Folded gauze pads were put behind the
eart to obtain proper exposure and to aid in stabilization. A
tabilizer system (Octopus III; Medtronic, Inc, Minneapolis, Minn)
as used for segmental stabilization of the myocardium adjoining
he target vessels. Coronary arteries were occluded proximally and
istally with silicone sutures. No drugs were administered to
ecrease the heart rate. An intracoronary shunt (Anastoflo Intra-
ascular Shunt; Research Medical, Inc, Salt Lake City, Utah) was
sed only in case of relative electrocardiographic or hemodynamic
nstability or with excessive bleeding during the construction of
he distal anastomosis. The proximal anastomoses were created
ith partial clamping of the aorta after completion of all distal
nastomoses. Fluid administration was used together with incre-
ents of ephedrine to maintain the mean systemic pressure at 60
m Hg or greater during manipulation of the heart for construction
f the distal anastomosis.
eparin and Protamine Management
n both groups, heparin was administered before distal transection
f the left internal thoracic artery. In the on-pump group heparin
as given at a dose of 300 IU/kg to achieve a target activated
lotting time (ACT) of 480 seconds or greater before commence-
ent of CPB. The ACT, obtained with kaolin, was monitored
uring the bypass period (every 30 minutes), and an additional
000 IU of heparin was administered if required. In the off-pump
roup heparin (150 IU/kg) was administered to achieve an ACT of
50 to 350 seconds. On completion of all anastomoses, the heparin
ffect was reversed with protamine sulfate at a ratio of 1:1 in
ABG cases and at a ratio of not greater than 0.5:1 in OPCAB
ases. In ONCAB cases further doses of 50 mg of protamine were
dministered when needed to obtain an ACT equal to or shorter
han the baseline values.
lood Sampling
lood samples were obtained on 2 occasions: 1 day before the
peration and 2 hours postoperatively in both groups of patients.
reoperative blood samples were collected by means of clean
enipuncture with a 21-gauge butterfly infusion set with a minimal
ourniquet. Samples obtained at 2 hours postoperatively were
btained from a central venous catheter (first 10 mL discarded).
he first 3 mL of blood was collected in dipotassium ethylenedi-
mine tetra-acetic acid vaccutainers. The next 4 mL of blood was
ollected in a polypropylene tube containing a one-tenth volume of
.8% trisodium citrate.
ematologic Indices and Platelet Studies
emoglobin values, hematocrit values, platelet counts, and mean
latelet volume were measured with an automated blood analyzer
Coulter-STKS; Coulter Electronics, Inc, Hileah, Fla). The platelet
ounts were corrected for hemodilution. All determinations of
rothrombin time and activated partial thromboplastin time vari-
and Cardiovascular Surgery ● Volume 134, Number 1 133
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CSPbles were performed with a fully automated coagulometer (STA4;
iagnostica Stago, Asnier sur Seine, France). Bleeding time was
easured by using the Ivy method. Flow cytometry was used to
etermine the percentage of activated platelets expressing Annexin
and P-selectin by using the Coulter XL-MLC flow cytometer
Coulter Electronics, Inc). Platelet aggregation was performed
ith 10 m of adenosine diphosphate (ADP)–stimulated platelet
ggregometry (Chronolog Aggregometer; Chronolog Corporation,
averton, Pa).
low Cytometry
e measured P-selectin– and Annexin V–positive platelets as
arkers of platelet activity. P-selectin surface translocation is
n expression of platelet activation caused by shear stress and is
lso referred to as GMP-140, platelet activation– dependent
ranule external membrane protein. Similarly, Annexin V binds
o microparticles released by activated platelets. Five-microliter
liquots of platelet-rich plasma were added to polypropylene
ubes preloaded with 45 L of phosphate-buffered saline and
aturating concentrations of one of the fluorescent isothiocyanate–
onjugated monoclonal antibody probes (Mouse AntiHuman
D62P FITC; Serotec, Oxford, United Kingdom) for detection of
ctivation with P-selectin. For detection of activation with An-
exin V, 5 L of platelet-rich plasma was added to a tube con-
aining 45 L of binding buffer (10 mM Hepes/NaOH [pH 7.4],
40 mM NaCl, and 2.5 mM CaCl2) and 10 L of Annexin V
abeled with fluorescein isothiocyanate (Annexin V FITC ASSAY
IT, Serotec). Immunolabeling of platelets with monoclonal anti-
odies and Annexin V was performed with 1-color analysis by
sing flow cytometry. Nonspecific membrane immunofluores-
ence was determined by using isotype-matched control antibod-
es. Samples were incubated in the dark without stirring for 15
inutes at room temperature and then diluted with 1 mL of
hosphate-buffered saline for samples containing the monoclonal
ntibodies for P-selectin and 1 mL of binding buffer for samples
ontaining the Annexin V. Samples were analyzed by means of
ow cytometry within 2 hours of collection. No fixative was used
ecause the fixative might change platelet antigenicity or cause
ell clumping. Platelet samples were analyzed with a Coulter
L-MLC flow cytometer (Coulter Electronics, Inc). The analyses
ere performed for 10,000 events in each sample. Logarithmic
mplification was used for the fluorescence signals, and linear
mplification was used for light-scattering signals. The platelet
opulation was identified on the basis of the forward and sideways
cattering characteristics. For the data analysis to determine the
ercentage of activated platelets, the threshold for platelet activa-
ion was set at the percentage of fluorescence-positive platelets in
amples corrected for the percentage contributed by the nonspe-
ific binding of isotype-matched control antibodies.
latelet Aggregation
latelet aggregation was performed with 10 m of ADP-stimulated
latelet aggregometry (Chronolog Aggregometer; Chronolog Corpo-
ation) in platelet-rich plasma. Platelet-rich plasma was adjusted to a
latelet count of approximately 250,000/L, and aggregation was
easured at room temperature. o
34 The Journal of Thoracic and Cardiovascular Surgery ● Julytatistical Analysis
he data were collected by using a data collection format. Data are
eported as medians with interquatile ranges, and analysis was
one with SPSS version 12.0 software. The Wilcoxon signed-rank
est was used to compare the difference (or change) in a numeric
ariable observed for 2 paired or matched groups and for before-
nd-after measurements made on the same group of subjects,
hereas the 2 test was used for categoric variables.
esults
o substantial differences in baseline characteristics were
bserved between the 2 groups, as shown in Table 1.
esult of inherent difference between the 2 surgical tech-
iques of coronary revascularization, the operative time was
ignificantly longer for the ONCAB group compared with
hat for the OPCAB group. Similarly, heparin and prota-
ine doses were significantly higher for the former cohort
Table 2). The need for packed red blood cell, fresh f
lasma, or platelet transfusions was similar in the 2 groups
Table 3). No substantial differences in clinical outco
ere observed between the 2 cohorts (Table 3).
Table 4 shows the preoperative baseline studies of p
et function. The preoperative platelet count, platelet vol-
me, bleeding time, and selectin- and Annexin V–positive
irculating platelet count were similar in the 2 groups. T
 also demonstrates the influence of ONCAB and OPC
ABLE 1. Clinical characteristics of patients
haracteristics OPCAB group ONCAB group P value
30 30
ge (y), median (IQR) 57 (48-69) 58 (49-69) NS
emale sex 8 (26.7%) 9 (30%) .77
MI (kg/m2), median
(IQR)
29.4 (27-31.8) 29.7 (27-32) NS
YHA class
I 8 (26.7%) 6 (20%) .54
II 22 (73.3%) 24 (80%) NS
CS grade
2 21 (70%) 20(66.7%) .78
3 9 (30%) 10 (33.3%) NS
emoglobin (g/dL),
median (IQR)
14.3 (13.0-15.2) 14.2 (13.0-15.6) NS
iabetes 13 (43.3%) 10 (33.3%) .43
ypertension 11 (36.7%) 10 (33.3%) .79
urrent Smokers 16 15 NS
o. of diseased vessels 4 4 NS
eft ventricular ejection
fraction (%),
median (IQR)
51 (45-58) 50 (43-58) .92
PCAB, Off-pump coronary artery bypass surgery; ONCAB, on-pump cor-
nary artery bypass surgery; IQR, interquartile range; BMI, body mass
ndex; NYHA, New York Heart Association; CCS, Canadian Cardiovascular
ociety.n platelet function in the preoperative and postoperative
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Periods, respectively. Of note, there was a significant reduc-
ion in platelet count and an increase in P-selectin– and
nnexin V–positive platelets after the operation in the
PCAB group. However, these changes did not signifi-
antly affect bleeding time or ADP-induced platelet aggre-
ation in patients undergoing OPCAB after the procedure.
imilarly, a postoperative decrease in platelet count and an
ncrease in P-selectin and Annexin V–positive platelets were
bserved among patients undergoing on-pump surgery. These
hanges (both absolute and percentage change from baseline)
n the ONCAB group were more pronounced compared with
hose in the OPCAB group (Table 5 and Figure 1). Add
lly, a significant increase in the bleeding time and a de-
rease in ADP-induced platelet function were also observed
n the ONCAB group.
Finally, there was no statistically significant relationship
etween preoperative versus postoperative changes in ADP-
nduced platelet aggregation and perioperative volume of
lood loss (R  0.45, P  .23). Similarly, no significant
elationship was noted between changes in the preoperative
ersus postoperative P-selectin– and Annexin V–positive
latelets and perioperative blood loss (R  0.34 and R 
.47, P  .18 and P  .31, respectively).
iscussion
n this study we confirmed the previously reported postop-
ABLE 2. Operative characteristics of patients
Operative characteristics O
Operative time (min), median (IQR) 205
CPB time (min), median (IQR)
Aortic crossclamp time (min), median (IQR)
Distal anastomosis, median (IQR) 2
Total heparin dose (IU/kg), median (IQR) 1
Total protamine dose (mg), median (IQR)
Maximum ACT (s), median (IQR) 2
PCAB, Off-pump coronary artery bypass surgery; ONCAB, on-pump coro
ABLE 3. Clinical outcomes of patients
Clinical outcomes
Death
Myocardial infarction
Stroke
Postoperative blood loss at 2 h (mL), median (IQR)
Blood transfusions (U), median (IQR)
Fresh frozen plasma (U), median
Platelet transfusions (U), median
LOS in ICU (d), median (IQR)
LOS in hospital (d), median (IQR)
Hemoglobin at discharge (g/dL), median (IQR)
PCAB, Off-pump coronary artery bypass surgery; ONCAB, on-pump cororative decrease in platelet count, as well as activation of t
The Journal of Thoracic-
latelets, in patients undergoing ONCAB.12 We noted an
ncrease in P-selectin– and Annexin V–positive platelets
nd also a decrease in ADP-induced platelet aggregation.
hese changes in platelet count and function were associ-
ted with a significant increase in bleeding time. Direction-
lly similar postoperative changes, although less marked,
ere observed in the OPCAB group, with a reduction in
latelet count and an increase in the markers of platelet
ctivation, such as P-selectin and Annexin V positivity.
owever, unlike those in the ONCAB group, these changes
enoting platelet function were not associated with either an
ncrease in bleeding time or a decrease in ADP-induced
latelet aggregation.
Thrombocytopenia has been well documented in patients
ndergoing on-pump surgery and has been attributed to
any factors, including hemodilution, mechanical disrup-
ion, adhesion to the extracorporeal circuit, and sequestra-
ion in organs.13 Additionally, platelet dysfunction has al
een shown to occur during on-pump surgery, resulting
oth in the prolongation of the bleeding time and the de-
rease in ADP-induced platelet aggregation. Similarly, prior
nvestigators have attested to platelet activation after use of
ardiopulmonary bypass.14 Although there is a lack of c-
ensus as to the pathophysiology of platelet activation,
any potential explanations have been entertained. Notable
mong these are exposure to synthetic material of the ex-
group ONCAB group P value
80–230) 268.0 (240–284) .0001
75.0 (60–85) —
51.3 (30–70) —
–3) 2.9 (2–4) .38
40–165) 321.67 (300–330) .0001
5–100) 324 (300–340) .0001
45–260) 400 (380–430) .0001
artery bypass surgery; IQR, interquartile range.
CAB group ONCAB group P value
1 0 NS
0 0 NS
0 0 NS
(100–180) 250 (230–300) .01
(0.5–2) 1.8 (1–2) NS
0 3 .42
0 0 NS
(1–2) 1.5 (1–2) NS
(5–8) 7 (6–8) NS
(10.0–12.2) 11.6 (10.5–12.5) NS
artery bypass surgery; IQR, interquartile range; LOS, length of stay.PCAB
.5 (1
—
—
.7 (2
50 (1
84 (7
50 (2OP
130
1
1
6
11.5racorporeal circuits, generation of thrombin, and use of
and Cardiovascular Surgery ● Volume 134, Number 1 135
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CSPeparin and protamine.15-17 These decreases in platele
ounts and abnormalities of platelet function and activity
ave been implicated by many not only in the bleeding
omplications in the postoperative period but also in the
hrombotic events (ie, recurrent ischemic events and type I
nd II neurologic injuries).18-21 The fact that these chang
ere less pronounced in the OPCAB group compared with
n the ONCAB group attests to the relatively “preserved
emostasis” in the former group compared with the latter
ohort and could potentially account for some of the differ-
nces in clinical outcomes between these 2 techniques re-
orted previously.
Our findings should be viewed in light of previously
ublished studies that evaluated hemostatic profile after
PCAB. Englberger and colleagues22 reported signifi-
antly lower values of fibrin monomer, thrombin-
ntithrombin complex, and D-dimer values in patients
ndergoing OPCAB compared with those in the ONCAB
roup, reflecting preserved coagulant and fibrinolytic ac-
ivity. Lo and associates23 found a significantly less pr-
ounced activation of coagulation and fibrinolysis in the
ABLE 4. Preoperative and postoperative platelet studies
Preoperative
OPCAB
Preoperativ
ONCAB
leeding time (min),  % median
(IQR)
2.0 (1.8–2.3) 2.0 (1.8–2.
latelet count ( 103/L),  %
median (IQR)
262 (230–284) 285.6 (248–2
ean platelet volume (fl),  %
median (IQR)
7.8 (7.7–8.0) 7.7 (7.6–8.
DP aggregation (%),  % median
(IQR)
61.6 (58–63) 60.9 (57–64
-selectin–positive platelets (%), 
% median (IQR)
5.3 (4.7–5.6) 5.2 (4.7–5.
nnexin V–positive platelets (%), 
% median (IQR)
0.77 (0.5–0.9) 0.72 (0.5–0.
PCAB, Off-pump coronary artery bypass surgery; ONCAB, on-pump corona
ABLE 5. Changes in platelet studies between the OPCAB
OPC
leeding time (min),  % median (IQR) 5 (
latelet count, ( 103/L),  % median (IQR) 30 (
ean platelet volume (fl),  % median (IQR) 3 (
DP aggregation (%),  % median (IQR) 1.29 (
-selectin–positive platelets (%),  % median (IQR) 113 (
nnexin V–positive platelets (%),  % median (IQR) 212 (
PCAB, Off-pump coronary artery bypass surgery; ONCAB, on-pump coronaPCAB group compared with that seen in the ONCAB O
36 The Journal of Thoracic and Cardiovascular Surgery ● Julyroup in the immediate postoperative period. However,
here was a delayed postoperative response in the OPCAB
roup, leading to a delayed increase (20-96 hours) in these
ariables and resulting in no differences in these values at a
ater time point. Similarly, Czerny and coworkers24 found
hat in the early postoperative period the levels of interleu-
in 10, intercellular adhesion molecule 1, and P-selectin
ere all lower in patients undergoing OPCAB than in
atients undergoing ONCAB. However, these values were
imilar thereafter between the 2 groups beyond 4 hours after
urgical intervention. Other investigators have shown sim-
lar lesser changes in platelet function after OPCAB in the
mmediate postoperative period compared with values seen
fter ONCAB surgery.25-27 Our findings are consistent wi
hese studies, and our data indicate a lesser influence of
PCAB compared with ONCAB on platelet function in the
mmediate postoperative period, supporting the concept of
reater preservation of hemostatic mechanisms with the
ormer technique. In contrast, Parolari and associate28
ound no differences in the postoperative tissue factor and
-selectin expression between patients in the OPCAB and
tients undergoing OPCAB and ONCAB
P
value
2 h
postoperative
OPCAB
P value vs
preoperative
OPCAB
2 h
postoperative
ONCAB
P value
vs
preoperative
ONCAB
1.00 1.9 (1.7–2.0) .37 3.3 (2.9–3.6) .0001
.73 183.8 (172–193) .0001 155.6 (143–167) .0001
.28 8.1 (7.9–8.2) .2 8.1 (7.9–8.2) .36
.46 60.8 (57–62) .42 50.0 (47–53) .0001
.60 11.3 (9–13.7) .0001 14.3 (13–15.2) .0001
.43 2.5 (1.3–3.4) .0001 4.4 (3.5–4.9) .0001
tery bypass surgery; IQR, interquartile range; ADP, adenosine diphosphate.
ONCAB groups
roup ONCAB group
P value for differences
between the 2 groups
8) 60 (40 to 75) .0001
o33) 40 (35- to43) .002
) 5 (2 to 6) .20
3) 17 (14.3 to 20) .0001
128) 175 (150 to 205) .003
230) 528 (478 to 555) .0001
tery bypass surgery; IQR, interquartile range; ADP, adenosine diphosphate.in pa
e
2)
93)
0)
)
5)
88)and
AB g
0 to
25 t
2 to 4
0 to
90 to
182 toNCAB groups in the first month after CABG. The differ-
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Pnt timings in the above studies for the measurement of
oagulation, platelet function, and fibrinolytic activity might
xplain some of the differences noted in these studies.
We are unable to determine the exact cause for these
hanges, but we can speculate on some potential reasons. It is
ikely that platelet activation might be attributed to the overall
emostatic response to promote healing of surgical wounds
nd to inflammation that accompanies surgical intervention.
lternatively, contribution of heparin and protamine to some
egree cannot be entirely excluded. Although future studies are
eeded to determine why these changes occur despite a lack of
ardiopulmonary bypass, it is likely that the potential for less
leeding, as well as for a preserved hemostatic state, might
xplain some of the clinical differences in outcomes between
he 2 techniques.6,8-11,21
Finally, the lack of a significant relationship between pre-
perative versus postoperative changes in ADP-induced plate-
et aggregation and P-selectin– and Annexin V–positive plate-
ets might be related to the small number of patient studies.
lternatively, given that flow cytometry is an extremely sen-
itive method for monitoring platelets, our data indicate that
latelet function needs to be considered in light of other factors
hat promote hemostasis, and overall bleeding in the perioper-
tive period is the sum of this multitude of factors that affect
emostasis rather than platelet function alone. Clearly, addi-
ional studies in a large number of patients might help provide
Figure 1. Off-pump (OPCAB) compared with on-pump (
percentage changes in postoperative platelet study va
Adenosine diphosphate.dditional insight into these factors. o
The Journal of Thoracictudy Limitations
ur study involves a small number of patients, and these
ndings need to be confirmed in future studies in a larger
umber of patients. Additionally, this was a hypothesis-
enerating study, and inferences regarding cause-and-effect
elationship (particularly with regard to changes in platelet
unction and its influence on clinical outcomes) should be
ade with caution. We focused on early platelet function
fter surgical intervention. As such, inferences cannot be
ade regarding platelet function abnormalities beyond this
ime period. The inherent variation in heparin and prota-
ine regimen in the 2 revascularization strategies might
ave had an influence on the differences in platelet function
een in the 2 groups. Nonetheless, our goal was to access the
verall effects of the 2 approaches to CABG on platelet
unction rather than the individual influence of the proce-
ures and different heparin/protamine dosing on platelet
unction. Thus our findings and inferences are appropriate
hen viewed in this context.
onclusions
ompared with patients undergoing ONCAB, an early post-
perative decrease in platelet count and increase in platelet
ctivation occurs to a much lesser extent and does not alter
leeding time or ADP-induced platelet aggregation in pa-
ients undergoing OPCAB. This lack of significant effects
B) coronary artery bypass surgery. Differences in the
compared with preoperative values are shown. ADP,ONCA
luesn platelets might in part account for the potential decreased
and Cardiovascular Surgery ● Volume 134, Number 1 137
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CSPisk in bleeding and for preserved hemostasis seen in pa-
ients undergoing OPCAB compared with ONCAB. Future
nvestigations in a large number of patients are needed to
onfirm these preliminary observations, as well as to deter-
ine the implications of these findings on clinical outcomes
f patients undergoing OPCAB and ONCAB.18-21
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